Matthias Barz Selected Research

Matthias Barz Research Topics

18	Neoplasms (Cancer) 01/2022 - 09/2010
2	Melanoma (Melanoma, Malignant) 10/2021 - 02/2014
2	Inflammation (Inflammations) 10/2021 - 10/2017
2	Adenocarcinoma 10/2012 - 10/2009
1	Tuberculosis (Tuberculoses) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Chronic Hepatitis B 01/2021
1	Hypersensitivity (Allergy) 12/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Granuloma 01/2018
1	Fibrosarcoma 01/2018
1	Infections 01/2018
1	Liver Diseases (Liver Disease) 10/2017
1	Hepatitis 10/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Carcinoma (Carcinomatosis) 09/2010

11	PolymersIBA 01/2022 - 10/2009
7	Pharmaceutical PreparationsIBA 01/2022 - 10/2009
2	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2019
2	MicellesIBA 10/2021 - 10/2021
2	riboflavin-binding proteinIBA 12/2020 - 01/2017
2	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2020 - 01/2017
2	Liposomes (Liposome)IBA 12/2019 - 01/2018
2	Drug CarriersIBA 01/2018 - 01/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2014 - 09/2010
2	hydroxypropyl methacrylateIBA 05/2014 - 10/2012
1	Polyglutamic Acid (Polyglutamate)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 11/2021
1	Ion Channels (Ion Channel)IBA 11/2021
1	Cyclic NucleotidesIBA 10/2021
1	Adenosine Monophosphate (AMP)IBA 10/2021
1	IronIBA 10/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	OligodeoxyribonucleotidesIBA 01/2021
1	candesartanIBA 01/2021
1	Aligeron (AS 2)IBA 01/2020
1	Immunomodulating AgentsIBA 01/2019
1	MetalsIBA 01/2019
1	VaccinesIBA 02/2018
1	histidine-rich proteinsIBA 01/2018
1	DuxonIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Biocompatible Materials (Biomaterials)IBA 01/2018
1	Concanavalin AIBA 10/2017
1	SelectinsIBA 10/2017
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2017
1	AntibodiesIBA 01/2017
1	Peptides (Polypeptides)IBA 02/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2012

6	Therapeutics 01/2022 - 07/2014
3	Immunotherapy 01/2019 - 05/2014
1	Ligation 01/2022
1	Radiotherapy 01/2022
1	Precision Medicine 11/2021
1	Drug Therapy (Chemotherapy) 11/2021
1	Relaxation Therapy (Relaxation Technique) 01/2021
1	Immunomodulation 10/2017